@article{Whittaker:2022:10.1136/bmjresp-2021-001150,
author = {Whittaker, H and Van, Ganse E and Dalon, F and Nolin, M and Marrant-Micallef, C and Pison, C and Deslee, G and Quint, J and Belhassen, M},
doi = {10.1136/bmjresp-2021-001150},
journal = {BMJ Open},
title = {Differences in severe exacerbations rates and health care utilisation in COPD populations in the UK and France},
url = {http://dx.doi.org/10.1136/bmjresp-2021-001150},
volume = {9},
year = {2022}
}

Download

TY  - JOUR
AB  - IntroductionChronic obstructive pulmonary disease (COPD) is a leading cause of mortality in Europe; however, it is important to understand how clinical practice patterns differ between countries and how this might relate to disease outcomes, to identify ways of improving local disease management. We aimed to describe and compare the management of COPD patients in the UK and France between 2008 and 2017. MethodsWe used data from the Clinical Practice Research Datalink GOLD and Hospital Episode Statistics in the UK and the Echantillon Généraliste des Bénéficiaire in France to identify COPD patients each year between 2008 and 2017. We compared patient characteristics, all-cause mortality, and COPD exacerbations each year between 2008 and 2017 for patients in the UK and France separately. Health care utilisation and COPD exacerbations in 2017 were compared between France and the UK using t-tests and chi-squared tests. ResultsCOPD patients were similar in gender and comorbidities in both countries. In the UK, incidence of COPD exacerbations remained stable in the UK and France between 2007-2017. In 2017, the proportion of all-cause and COPD-related hospitalisations was greater in the UK than in France (43.9% vs. 32.8% and 8.3% vs 4.9%, respectively; p<0.001) as was the proportion of patients visiting accident and emergency (39.8% vs 16.2%, respectively; p<0.001). In addition, the mean length of stay in hospital for COPD related causes was shorted in the UK than in France (6.2 days (SD 8.4) vs 10.5 days (SD 9.1), respectively; p<0.001). DiscussionOverall, UK patients were more likely to go to accident and emergency (A&E) and be hospitalised for COPD-related causes and stay in hospital for fewer days after being admitted for COPD-related reasons compared to patients in France, illustrating a difference in health-seeking behaviours and access to healthcare.
AU  - Whittaker,H
AU  - Van,Ganse E
AU  - Dalon,F
AU  - Nolin,M
AU  - Marrant-Micallef,C
AU  - Pison,C
AU  - Deslee,G
AU  - Quint,J
AU  - Belhassen,M
DO  - 10.1136/bmjresp-2021-001150
PY  - 2022///
SN  - 2044-6055
TI  - Differences in severe exacerbations rates and health care utilisation in COPD populations in the UK and France
T2  - BMJ Open
UR  - http://dx.doi.org/10.1136/bmjresp-2021-001150
UR  - http://hdl.handle.net/10044/1/98631
VL  - 9
ER  - 

Download